Company: FMHS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001096906-25-001826
Chunk: 12

Company: FARMHOUSE, INC. /NV
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 12
---
 of debt of $5 for the nine months ended September 30, 2025 upon the exchange.

·Outstanding accrued legal fees and finance charges totaling $424,930 were exchanged for a new Series 2025 Note in the face amount of $250,000. The Company recorded a gain on extinguishment of debt of $174,930 for the nine months ended September 30, 2025 upon the exchange.

·An outstanding and overdue accounts payable of $8,270and accrued interest of $230 was exchanged for a new Series 2025 Note in the face amount of $8,500.

·A promissory note with a principal balance of $11,667 and accrued interest balance of $1,733, was exchanged for a new Series 2025 Note in the face amount of $13,400.

The following Series 2025 Notes were issued for cash during the nine months ended September 30, 2025

·$10,000issued to an unrelated individual on February 24, 2025.

·$25,000issued to an unrelated individual on April 16, 2025.

·$12,500issued to an unrelated individual on April 21, 2025.

·$12,500issued to an unrelated individual on April 28, 2025.

·$10,000issued to an unrelated individual on June 23, 2025.

·$15,000issued to an unrelated individual on August 15, 2025.

Interest expense related to the Series 2025 Notes was $20,424for the nine months ended September 30, 2025 and $10,849for the three months ended September 30, 2025. Accrued interest on the Series 2025 Notes was $20,424andzeroas of September 30, 2025 and December 31, 2024, respectively.

NOTE 8 - STOCKHOLDERS’ DEFICIT

The Company is authorized to issue295,000,000shares of common stock, $0.0001par value per share, and5,000,000shares of undesignated preferred stock, $0.0001par value per share. The Board of Directors has the authority, in its sole discretion, to establish series of preferred stock and to fix the par value, dividend rates, designations, preferences, privileges, and restrictions of each series. No shares of preferred stock were issued or outstanding as of September 30, 202